Fujifilm Holdings Corp said it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States.
The trial will enrol about 50 COVID-19 patients in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital, and the University of Massachusetts Medical School, Fujifilm said on Thursday.
On March 31, Fujifilm announced the start of phase III clinical trial of Avigan for COVID-19 patients in Japan.
The death toll from a building collapse in George, South Africa, has increased to 19,…
Egypt's Ministry of Foreign Affairs on Sunday revealed that the country will formally join South…
Three individuals, two men and a woman, died Sunday, May 12 in an accident that occurred…
Mohamed Zitouna, spokesperson for the Tunis Court of First Instance, clarified the latest development of…
We often speak about the damage of obesity in the USA, Egypt, etc. But what…
According to Amer Bahbouha, professor of geography and specialist in meteorology, we will quickly have…
This website uses cookies.